Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects
Clinical trial NCT03927391 · COMPLETED
Trial details
- NCT number
- NCT03927391
- Sponsor
- Radboud University Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2024-01-08
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.